Tilray, Inc. Business Finance Contracts & Agreements

84 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Credit Agreement among Aphria Diamond Inc., Aphria Inc., Double Diamond Holdings Ltd., Tilray Brands, Inc., Subsidiary Guarantors, and Canadian Imperial Bank of Commerce
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2025
Non-Interest-Bearing Demand Promissory Note between Aphria Diamond Inc. and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2025
Fourth Amendment and Consent to Credit Agreement among American Beverage Crafts Group, Inc., Bank of America, N.A., and Lenders
Credit Agreements
Tilray, Inc.
Pharmaceuticals
MI
2024
Non-Interest-Bearing Demand Promissory Note between Aphria Diamond Inc. and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2024
Description of Tilray Brands, Inc. Capital Stock Registered Under Section 12(b) of the Exchange Act
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
2024
Equity Distribution Agreement between Tilray Brands, Inc. and TD Securities (USA) LLC and Jefferies LLC, dated May 17, 2024
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Amended and Restated Credit Agreement among Aphria Diamond Inc., Aphria Inc., Tilray Brands, Inc., Subsidiary Guarantors, and Bank of Montreal
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2024
Third Amendment and Consent to Credit Agreement among American Beverage Crafts Group, Inc., Guarantors, Lenders, and Bank of America, N.A.
Credit Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2024
Waiver to Credit Agreement among Four Twenty Corporation, Guarantors, Lenders, and Bank of America, N.A. (January 5, 2024)
Waiver Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Waiver to Credit Agreement among Four Twenty Corporation, Guarantors, Lenders, and Bank of America, N.A. (January 5, 2024)
Waiver Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Tilray Brands, Inc. 2023 EBITDA Performance Restricted Stock Unit Grant Notice (Amended and Restated 2018 Equity Incentive Plan)
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
2023
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Second Amendment and Consent to Credit Agreement among Four Twenty Corporation, Bank of America, N.A., and Others
Credit Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
First Amendment to Securities and Asset Purchase Agreement among Tilray Beverages, LLC, Tilray Brands, Inc., American Beverage Crafts, LLC, and Anheuser-Busch, LLC
Purchase Agreements
Tilray, Inc.
Pharmaceuticals
2023
Securities and Asset Purchase Agreement among Anheuser-Busch, Tilray, and Related Parties (August 7, 2023)
Purchase Agreements
Tilray, Inc.
Pharmaceuticals
WA
2023
Description of Tilray Brands, Inc. Class 2 Common Stock and Preferred Stock Rights
Stock Agreements
Tilray, Inc.
Pharmaceuticals
2023
Supplemental Warrant Indenture among HEXO Corp., Tilray Brands, Inc., and TSX Trust Company (June 22, 2023)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Supplemental Warrant Indenture among HEXO Corp., Tilray Brands, Inc., and TSX Trust Company (June 22, 2023)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Supplemental Warrant Indenture among HEXO Corp., Tilray Brands, Inc., and TSX Trust Company (June 22, 2023)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Supplemental Warrant Indenture among HEXO Corp., Tilray Brands, Inc., and TSX Trust Company (June 22, 2023)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Third Supplemental Warrant Indenture among Tilray Brands, Inc., HEXO Corp., and Computershare Trust Company of Canada (June 22, 2023)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
2023
Third Supplemental Warrant Indenture among Tilray Brands, Inc., HEXO Corp., and Computershare Trust Company of Canada (June 22, 2023)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
2023
Second Supplemental Warrant Indenture among 48North Cannabis Corp., HEXO Corp., Tilray Brands, Inc., and Computershare Trust Company of Canada
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
2023
Amendment and Consent Agreement between HEXO Corp. and Tilray Brands, Inc. regarding Private Placement and Note Covenants
Modification Agreements
Tilray, Inc.
Pharmaceuticals
2023
Share Lending Agreement between Tilray Brands, Inc. and Jefferies Capital Services, LLC dated May 25, 2023
Loan Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
First Supplemental Indenture to 5.20% Convertible Senior Notes due 2027 between Tilray Brands, Inc. and Computershare Trust Company, N.A.
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
Indenture Agreement between Tilray Brands, Inc. and Computershare Trust Company, N.A. dated May 31, 2023
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
Underwriting Agreement for $150,000,000 5.20% Convertible Senior Notes due 2027 by Tilray Brands, Inc. with Jefferies LLC and BofA Securities, Inc.
Underwriting Agreements
Tilray, Inc.
Pharmaceuticals
DC
2023
Temporary Waiver and Amendment Agreement between HEXO Corp. and Tilray Brands, Inc. (April 2023)
Waiver Agreements
Tilray, Inc.
Pharmaceuticals
2023
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Assignment and Assumption Agreement between Tilray Brands, Inc. and Double Diamond Holdings Ltd. (September 1, 2022)
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
2023
Amended and Restated Credit Agreement among 1974568 Ontario Limited, Aphria Inc., Tilray Brands, Inc., and Bank of Montreal, dated November 28, 2022
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2022
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Assignment and Assumption Agreement between Tilray Brands, Inc. and Double Diamond Holdings Ltd. (June 30, 2022)
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
2022
Tilray Brands, Inc. Restricted Stock Unit Grant Notice (2022 HEXO EBITDA Award) under Amended and Restated 2018 Equity Incentive Plan
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
2022
Description of Tilray Brands, Inc. Class 2 Common Stock and Preferred Stock Rights
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
2022